Ipca Laboratories Ltd.

NSE: IPCALAB | BSE: 524494

Expensive Performer

Download real time

1407.05 4.85 (0.35%)

33.75% Gain from 52W Low

321.7K NSE+BSE Volume

NSE 21 Mar, 2025 3:31 PM (IST)

2

Broker 1Year buys

2 active buys

0

Broker 1Year sells

0 active sells

1

Broker 1Year neutral

1 active holds

Ipca Laboratories Ltd. share price target

Ipca Laboratories Ltd. has an average target of 1815. The consensus estimate represents an upside of 28.99% from the last price of 1407.05. View 8 reports from 3 analysts offering long-term price targets for Ipca Laboratories Ltd..

Reco - This broker has downgraded this stock from it's previous report.
(eg. - Buy->Hold)

Target - Broker has maintained previous recommendation but reduced share price target.

Reco - This broker has upgraded this stock from it's previous report.
(eg. - Sell->Hold)

Target - Broker has maintained previous recommendation but increased share price target.

Click on any table column to sort reports by date, stock name, broker, price, target, upside or recommendation.

Summary	Date	Stock	Author	LTP	Target	Price at reco (Change since reco%)	Upside(%)	Type	Report		Discuss
	23 Mar 2025	Ipca Laboratories	Consensus Share Price Target	1407.05	1645.75	-	16.96	buy	pdf Detailed Estimates
	14 Feb 2025	Ipca Laboratories	Prabhudas Lilladhar	1407.05	1700.00	1463.90 (-3.88%)	20.82	Accumulate	pdf post cache		Broker Report IPCA LABORATORIES Prabhudas Lilladhar pdf Copy Link Share on Share on Share on Share on Alert
	27 Dec 2024	Ipca Laboratories	Motilal Oswal Target	1407.05	1980.00	1632.65 (-13.82%)	40.72	Buy	pdf post cache		Broker Report Scaling US operations/outpacing IPM to aid robust earnings growth Motilal Oswal Following a muted performance in the US over the past eight years due to compliance issues, IPCA is well-poised to revive its US business through new product launches, relaunches, stable pricing in its base business, and the integration of the Unichem business over the next 12-24M. pdf Copy Link Share on Share on Share on Share on Alert
	18 Nov 2024	Ipca Laboratories	Prabhudas Lilladhar Target	1407.05	1700.00	1566.70 (-10.19%)	Target met	Accumulate	pdf post cache		Broker Report IPCA LABORATORIES Prabhudas Lilladhar pdf Copy Link Share on Share on Share on Share on Alert
	14 Nov 2024	Ipca Laboratories	Sharekhan Target	1407.05	1765.00	1536.55 (-8.43%)	25.44	Buy	pdf post cache		Broker Report US recovery, Unichem acquisition set to drive growth Sharekhan Quarterly revenues reached Rs. 2,355 crore, marking a 16% y-o-y increase and a 13% rise from the previous quarter. Profit after tax (PAT) came in strong at Rs. 245 crore, up 39% as compared to last year and 23%, sequentially. pdf Copy Link Share on Share on Share on Share on Alert
	14 Oct 2024	Ipca Laboratories	Motilal Oswal Reco Target	1407.05	1950.00	1682.20 (-16.36%)	38.59	Buy	pdf post cache		Broker Report At an inflexion point Motilal Oswal After three years of earnings deterioration, IPCA is well-poised to deliver strong earnings growth over FY24-27. pdf Copy Link Share on Share on Share on Share on Alert
	30 Sep 2024	Ipca Laboratories	Sharekhan Target	1407.05	1734.00	1498.10 (-6.08%)	Target met	Buy	pdf post cache		Broker Report Bayshore integration to unlock growth Sharekhan Ipca’s board would discuss the strategic integration of Bayshore Pharmaceuticals’ generics business into Unichem Pharma (USA) Inc on September 30, 2024. pdf Copy Link Share on Share on Share on Share on Alert
	14 Aug 2024	Ipca Laboratories	Sharekhan Reco Target	1407.05	1600.00	1349.05 (4.30%)	Target met	Buy	pdf post cache		Broker Report Strong Q1; UniChem’s turnaround sustainable Sharekhan Ipca Laboratories Limited’s (Ipca) earnings came above our estimates, as sales grew 32.9% y-o-y to Rs. 2,092 crore. Sales growth was led by 11.6% y-o-y growth in domestic branded formulations. pdf Copy Link Share on Share on Share on Share on Alert
	14 Aug 2024	Ipca Laboratories	Motilal Oswal Target	1407.05	1310.00	1349.05 (4.30%)	Target met	Neutral	pdf post cache		Broker Report Domestic formulation drives earnings Motilal Oswal IPCA delivered better-than-expected 1QFY25 earnings. The improved performance in the domestic formulation (DF) segment was offset to some extent by a subdued show in exports and API segment. pdf Copy Link Share on Share on Share on Share on Alert
	16 Feb 2024	Ipca Laboratories	Prabhudas Lilladhar	1407.05	1060.00	1241.45 (13.34%)	Target met	Hold	pdf post cache		Broker Report IPCA LABORATORIES Prabhudas Lilladhar pdf Copy Link Share on Share on Share on Share on Alert
	11 Nov 2023	Ipca Laboratories	Prabhudas Lilladhar Target	1407.05	1060.00	1050.75 (33.91%)	Target met	Hold	pdf post cache		Broker Report IPCA LABORATORIES Prabhudas Lilladhar pdf Copy Link Share on Share on Share on Share on Alert
	11 Nov 2023	Ipca Laboratories	Motilal Oswal Target	1407.05	1000.00	1050.75 (33.91%)		Neutral	pdf post cache		Broker Report Efforts underway to revamp US generics business Motilal Oswal pdf Copy Link Share on Share on Share on Share on Alert
	22 Oct 2023	Ipca Laboratories	Motilal Oswal Target	1407.05	860.00	935.90 (50.34%)		Neutral	pdf post cache		Broker Report Clearance of Ratlam API site to uplift the US prospects Motilal Oswal pdf Copy Link Share on Share on Share on Share on Alert
	13 Aug 2023	Ipca Laboratories	Prabhudas Lilladhar Target	1407.05	880.00	907.05 (55.12%)	Target met	Hold	pdf post cache		Broker Report IPCA LABORATORIES Prabhudas Lilladhar pdf Copy Link Share on Share on Share on Share on Alert
	12 Aug 2023	Ipca Laboratories	Motilal Oswal Target	1407.05	840.00	907.05 (55.12%)		Neutral	pdf post cache		Broker Report Domestic formulation drives earnings Motilal Oswal pdf Copy Link Share on Share on Share on Share on Alert
	14 May 2023	Ipca Laboratories	Motilal Oswal	1407.05	760.00	695.40 (102.34%)	Target met	Neutral	pdf post cache		Broker Report Long road ahead for USFDA compliance Motilal Oswal pdf Copy Link Share on Share on Share on Share on Alert
	26 Apr 2023	Ipca Laboratories	Motilal Oswal Reco Target	1407.05	760.00	701.40 (100.61%)	Target met	Neutral	pdf post cache		Broker Report Risk-reward less favorable toward acquisition Motilal Oswal pdf Copy Link Share on Share on Share on Share on Alert
	26 Apr 2023	Ipca Laboratories	Sharekhan Target	1407.05	790.00	701.40 (100.61%)	Target met	Hold	pdf post cache		Broker Report Ipca Labs Sharekhan pdf Copy Link Share on Share on Share on Share on Alert
	25 Apr 2023	Ipca Laboratories	Prabhudas Lilladhar Target	1407.05	750.00	741.15 (89.85%)	Target met	Hold	pdf post cache		Broker Report IPCA LABORATORIES Prabhudas Lilladhar pdf Copy Link Share on Share on Share on Share on Alert
	17 Feb 2023	Ipca Laboratories	ICICI Direct Target	1407.05	885.00	830.90 (69.34%)	Target met	Hold	pdf post cache		Broker Report IPCA Laboratories ICICI Direct pdf Copy Link Share on Share on Share on Share on Alert
	17 Feb 2023	Ipca Laboratories	Prabhudas Lilladhar Target	1407.05	865.00	830.90 (69.34%)	Target met	Hold	pdf post cache		Broker Report IPCA LABORATORIES Prabhudas Lilladhar pdf Copy Link Share on Share on Share on Share on Alert
more loading

* Please note that subscribers can download a maximum of 300 reports a month and 70 reports everyday.

Advisor Screeners